Helen McCarthy
Queen’s University Belfast, Northern Ireland
Biography
Dr Helen McCarthy obtained her PhD in 2000 from University of Ulster. She then took a Research Associate post in the field of prostate cancer gene therapy at the University of Ulster. In July 2004 she moved to the School of Pharmacy, Queen's University Belfast to take the post of Research Fellow on a cancer gene therapy project, within the newly established, Experimental Therapeutics research cluster. She obtained a lectureship within the School of Pharmacy in November 2006, then Senior Lecturer in 2011 and Reader in 2013. For the last 10 years Dr McCarthy’s research team have focused on the development of non-viral delivery systems for nanomedicine. These biomimetic systems are designed to overcome the extra and intracellular barriers, so that the macromolecular payload can be delivered at the destination site in order to exert the optimal therapeutic effect. Dr McCarthy has published widely (>50 research papers), holds several patents on delivery systems in the nanotechnology area and has given numerous invited conference presentations. She has obtained significant research grant income from MRC, BBSRC, EPSRC, Cancer Research UK, Prostate Cancer UK, Breast Cancer Campaign, Royal Pharmaceutical Society of Great Britain, The Royal Society, National Science Foundation, Invest NI and Touchlight Genetics. She has also collaborated extensively both nationally and internationally and sits on the editorial board for Cancer Nanotechnology.
Abstract
